FDA Approves First mRNA Flu Vaccine For Older Adults

The approval of Moderna’s new flu vaccine comes months after the FDA faced backlash for refusing to review the shot.

FDA approves first mRNA-based flu vaccine

The US Food and Drug Administration on Wednesday approved the United States’ first mRNA-based flu vaccine for adults 50 and ...

MRNA Stock Pares Gains Despite FDA Green Light For First mRNA Flu Vaccine — But Retail Cheers Pivot Beyond COVID

The approval makes mFLUSIVA Moderna’s fourth FDA-cleared product and the first messenger RNA-based flu vaccine.

A new flu vaccine geared to older people is coming soon

The first mRNA-based flu shot to be approved by the Food and Drug Administration will be ready for the upcoming flu season.
Stocktwits on MSN

MRNA, LNTH, BMY, CAPR, RARE stocks in focus — these FDA decisions could shape August trading

Moderna is seeking approval for mRNA-1010, its experimental mRNA-based seasonal flu vaccine for adults 50 and older. ・Capricor is seeking full approval for Deramiocel, a cell therapy aimed at heart ...